These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
262 related articles for article (PubMed ID: 31064817)
1. Circulating microRNA-378 levels serve as a novel biomarker for assessing the severity of coronary stenosis in patients with coronary artery disease. Li H; Gao F; Wang X; Wu J; Lu K; Liu M; Li R; Ding L; Wang R Biosci Rep; 2019 May; 39(5):. PubMed ID: 31064817 [No Abstract] [Full Text] [Related]
2. Circulating miRNA-33: a potential biomarker in patients with coronary artery disease. Reddy LL; Shah SAV; Ponde CK; Rajani RM; Ashavaid TF Biomarkers; 2019 Feb; 24(1):36-42. PubMed ID: 30022694 [TBL] [Abstract][Full Text] [Related]
3. Potential of circulating pro-angiogenic microRNA expressions as biomarkers for rapid angiographic stenotic progression and restenosis risks in coronary artery disease patients underwent percutaneous coronary intervention. Dai R; Liu Y; Zhou Y; Xiong X; Zhou W; Li W; Zhou W; Chen M J Clin Lab Anal; 2020 Jan; 34(1):e23013. PubMed ID: 31495986 [TBL] [Abstract][Full Text] [Related]
4. Circulating MicroRNA-423-3p Improves the Prediction of Coronary Artery Disease in a General Population - Six-Year Follow-up Results From the China-Cardiovascular Disease Study. Wang X; Dong Y; Fang T; Wang X; Chen L; Zheng C; Kang Y; Jiang L; You X; Gai S; Wang Z; Cao H Circ J; 2020 Jun; 84(7):1155-1162. PubMed ID: 32404537 [TBL] [Abstract][Full Text] [Related]
5. miR-941 as a promising biomarker for acute coronary syndrome. Bai R; Yang Q; Xi R; Li L; Shi D; Chen K BMC Cardiovasc Disord; 2017 Aug; 17(1):227. PubMed ID: 28830367 [TBL] [Abstract][Full Text] [Related]
6. Kinetics of Circulating MicroRNAs in Response to Cardiac Stress in Patients With Coronary Artery Disease. Jansen F; Schäfer L; Wang H; Schmitz T; Flender A; Schueler R; Hammerstingl C; Nickenig G; Sinning JM; Werner N J Am Heart Assoc; 2017 Jul; 6(8):. PubMed ID: 28751542 [TBL] [Abstract][Full Text] [Related]
7. Potential value of circulating microRNA-126 and microRNA-210 as biomarkers for type 2 diabetes with coronary artery disease. Amr KS; Abdelmawgoud H; Ali ZY; Shehata S; Raslan HM Br J Biomed Sci; 2018 Apr; 75(2):82-87. PubMed ID: 29452547 [TBL] [Abstract][Full Text] [Related]
8. Association of Plasma MiRNA-204 and the Presence and Severity of Coronary Artery Calcification in Patients With Type 2 Diabetes. Ding YD; Pei YQ; Rui-Wang ; Yang JX; Zhao YX; Liu XL; Shen H; Ma Q; Zhang S; Ge HL Angiology; 2021 May; 72(5):451-458. PubMed ID: 33401931 [TBL] [Abstract][Full Text] [Related]
9. Association between elevated plasma microRNA-223 content and severity of coronary heart disease. Guo JF; Zhang Y; Zheng QX; Zhang Y; Zhou HH; Cui LM Scand J Clin Lab Invest; 2018 Sep; 78(5):373-378. PubMed ID: 29888618 [TBL] [Abstract][Full Text] [Related]
10. Plasma MicroRNA-126-5p is Associated with the Complexity and Severity of Coronary Artery Disease in Patients with Stable Angina Pectoris. Li HY; Zhao X; Liu YZ; Meng Z; Wang D; Yang F; Shi QW Cell Physiol Biochem; 2016; 39(3):837-46. PubMed ID: 27497911 [TBL] [Abstract][Full Text] [Related]
11. Circulating Extracellular miRNA Analysis in Patients with Stable CAD and Acute Coronary Syndromes. Zhelankin AV; Stonogina DA; Vasiliev SV; Babalyan KA; Sharova EI; Doludin YV; Shchekochikhin DY; Generozov EV; Akselrod AS Biomolecules; 2021 Jun; 11(7):. PubMed ID: 34209965 [TBL] [Abstract][Full Text] [Related]
12. Altered Plasma miR-144 as a Novel Biomarker for Coronary Artery Disease. Chen B; Luo L; Wei X; Gong D; Jin L Ann Clin Lab Sci; 2018 Jul; 48(4):440-445. PubMed ID: 30143484 [TBL] [Abstract][Full Text] [Related]
13. Clinical significance of circulating microRNAs as diagnostic biomarkers for coronary artery disease. Zhang L; Zhang Y; Xue S; Ding H; Wang Y; Qi H; Wang Y; Zhu W; Li P J Cell Mol Med; 2020 Jan; 24(1):1146-1150. PubMed ID: 31709737 [TBL] [Abstract][Full Text] [Related]
14. miRNA 206 and miRNA 574-5p are highly expression in coronary artery disease. Zhou J; Shao G; Chen X; Yang X; Huang X; Peng P; Ba Y; Zhang L; Jehangir T; Bu S; Liu N; Lian J Biosci Rep; 2015 Dec; 36(1):e00295. PubMed ID: 26685009 [TBL] [Abstract][Full Text] [Related]
15. Association between circulating microRNA-208a and severity of coronary heart disease. Zhang Y; Li HH; Yang R; Yang BJ; Gao ZY Scand J Clin Lab Invest; 2017 Sep; 77(5):379-384. PubMed ID: 28554251 [TBL] [Abstract][Full Text] [Related]
16. The potential value of Copeptin and Pentraxin3 for evaluating the severity of coronary stenosis in patients with coronary artery disease. Cao RY; Yang J; Zheng Y; Li H; Zhao Q; Ding Y; Li Q; Liu S; Wang L; Zheng H Clin Biochem; 2021 Jan; 87():32-38. PubMed ID: 33080253 [TBL] [Abstract][Full Text] [Related]
17. MiR-33 may be a Biological Marker for Coronary Heart Disease. Xie Z; Ma P Clin Lab; 2018 Oct; 64(10):1755-1760. PubMed ID: 30336533 [TBL] [Abstract][Full Text] [Related]
18. Circulating microRNAs as biomarkers for severe coronary artery disease. Zhang X; Cai H; Zhu M; Qian Y; Lin S; Li X Medicine (Baltimore); 2020 Apr; 99(17):e19971. PubMed ID: 32332683 [TBL] [Abstract][Full Text] [Related]
19. Increased Serum Level of Growth Differentiation Factor 15 (GDF-15) is Associated with Coronary Artery Disease. Wang X; Chen LL; Zhang Q Cardiovasc Ther; 2016 Jun; 34(3):138-43. PubMed ID: 26996787 [TBL] [Abstract][Full Text] [Related]